Published on 15 Sep 2023 on Zacks via Yahoo Finance
Here's Why You Should Retain Cencora (COR) Stock for Now
Cencora, Inc. COR is well poised for growth on the back of robust U.S. Healthcare Solutions business and product launches. However, intense competition is a concern.
Shares of this currently Zacks Rank #3 (Hold) company have risen 6.8% year to date against the industry’s 10.3% decline. The S&P 500 Index has increased 17.5% in the same time frame.
Cencora is one of the world’s largest pharmaceutical service companies, focused on providing drug distribution and related services to reduce healthcare costs and improve patient outcomes. It has a market capitalization of $35.72 billion. The company changed its name from AmerisourceBergen to Cencora (on Aug 30) and its ticker from ABC to COR.